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Our ability to detect cancerous lesions *in vivo* is limited by the quality of scans such as PET, MRI, and computed tomography. Currently, we are only able to detect macrolesions. There is growing interest, therefore, in the use of applying fluorescently labeled antibodies against tumor markers to identify microlesions *in vivo*. Techniques previous to this experiment did not possess the necessary sensitivity or specificity to detect microlesions. Using two-photon excitation microscopy and fluorophore-conjugated anti-carcinoembryonic antigen antibody, Koga and colleagues were able to detect with exquisite sensitivity and specificity cancerous microlesions *in vivo* in mouse models. This exciting new application of technology holds great promise for the future and the possibility of earlier detection of cancerous lesions.
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Hepatocellular carcinoma (HCC) is traditionally associated with alcoholic liver cirrhosis and hepatitis viruses. Non-alcoholic steatohepatitis (NASH) is another form of liver disease that is not associated with either alcohol intake or infection with hepatitis viruses, but the mechanisms of developing HCC from NASH are not well understood. In this edition of *Cancer Science*, Takaki and colleagues present their findings of a microRNA, miR-122, that may be linked to NASH-associated HCC. Using a multidisciplinary approach that used both a mouse model of NASH--HCC and human clinical tissue samples, the authors describe their findings that miR-122 expression is inversely correlated with progression to liver cirrhosis, NASH, and HCC. Their findings point to a previously unknown link between the microRNA miR-122 and NASH-associated HCC, which should assist further research into the mechanism of this type of liver cancer.
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The mechanism by which gallbladder carcinoma develops and progresses is currently not well understood. Similarly, the molecular pathways underlying lymphangiogenic spread are a topic of active research. Based on prior work that identified a potential role for tumor necrosis factor-α (TNF-α) and vascular endothelial growth factor-C (VEGF-C) in the progression of gallbladder cancer and lymphangiogenic spread, Du et al. hypothesized a causative role of TNF-α through induction of VEGF-C in gallbladder carcinogenesis. To test this, they obtained human samples of gallbladder carcinoma and bile and compared these to samples from individuals without cancer. Interestingly, they found a close association between the levels of TNF-α and VEGF-C. To further their understanding of this process, the authors carried out *in vitro* studies to reveal the action of TNF-α through nuclear factor-κB to induce VEGF-C and lead to lymphatic tube formation. In doing so, these authors further our understanding of the molecular mechanisms of gallbladder carcinogenesis.
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